These findings emphasized that by undergoing a phenotypic switch from proliferative, highly differentiated MITF subpopulations to invasive, de-differentiated MITF subpopulations, melanoma cells potentially became resistant to ICB therapy. The gene discussed is MITF; the disease is melanoma.